Researcher
Peter Vandenabeele
- Keywords (Ghent University):Cell death and inflammation
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Ghent University):Biophysics, Molecular and cell biology, Laboratory medicine, Microbiology, Systems biology, Plant biology, Medicinal and biomolecular chemistry, Molecular and cell biology not elsewhere classified
Affiliations
- Vandenabeele Lab (Research group)
Responsible
From1 Jan 2017 → Today - Board of Governors/Executive Board (Administrative office)
Member
From1 Oct 2012 → Today - Department of Biomedical molecular biology (Department)
Member
From1 Oct 1993 → Today - Department of Plant Biotechnology and Bioinformatics (Department)
Member
From1 Jan 1993 → 30 Sep 1993
Projects
1 - 10 of 69
- Role and mechanism of caspase-3/7 as checkpoint for intestinal inflammation and regenerationFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Role of ZBP1 signalling in doxorubicin-mediated anticancer immunity and drug-induced pathologyFrom1 Oct 2023 → TodayFunding: BOF - projects
- Stichting tegen Kanker: Advanced technology equipment: Small Animal Radiation Therapy platform (SmART+)From1 Jul 2022 → TodayFunding: Foundations, funds and other with scientific goal
- SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomicsFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Mechanisms of ferroptosis mediated immunoregulationFrom1 Jan 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Cell Death Regulation and Role in Infection and Inflammatory DiseasesFrom1 Jan 2022 → TodayFunding: FWO EOS
- Investigating Trans-Generational Training Networks in Central Africa: A Multi-Layered Analysis of Pottery TechnologyFrom1 Oct 2021 → TodayFunding: FWO senior postdoctoral fellowship
- Improving cancer therapy by modulating cell death and the microbiome in the gutFrom1 Mar 2021 → 29 Feb 2024Funding: Foundations, funds and other with scientific goal
- Autophagy in inflammation and inflammatory disorders (ATLANTIS), from basic insights to experimental therapyFrom1 Jan 2021 → TodayFunding: BOF - iBOF
- Investigating the immunoregulatory properties of ferroptosis in experimental cancer modelsFrom1 Nov 2020 → TodayFunding: FWO fellowships
Publications
31 - 40 of 306
- XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells(2021)
Authors: Adam Wahida, Madeleine Mueller, Andreas Hiergeist, Bastian Popper, Katja Steiger, Caterina Branca, Markus Tschurtschenthaler, Thomas Engleitner, Sainitin Donakonda, Rupert Oellinger, et al.
- A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency(2021)
Authors: Julie Le Naour, Peng Liu, Liwei Zhao, Sandy Adjemian Catani, Zsofia Sztupinszki, Julien Taieb, Claire Mulot, Aymeric Silvin, Charles-Antoine Dutertre, Florent Ginhoux, et al.
Pages: 408 - 423 - Necroptosis signalling promotes inflammation, airway remodelling and emphysema in COPD(2021)
Authors: Zhe Lu, Hannelore Van Eeckhoutte, Gang Liu, Prema M Nair, Bernadette Jones, Caitlin Gillis, B. Christina Nalkurthi, Fien Verhamme, Tamariche Buyle-Huybrecht, Peter Vandenabeele, et al.
Pages: 667 - 681 - Microbes exploit death-induced nutrient release by gut epithelial cells(2021)
Authors: Christopher Anderson, Christopher B. Medina, Brady J. Barron, Laura Karvelyte, Tania Love Aaes, Irina Lambertz, Justin S. A. Perry, Parul Mehrotra, Amanda Gonçalves, Kelly Lemeire, et al.
Pages: 262 - 267 - Patients with COVID-19 : in the dark-NETs of neutrophils(2021)
Authors: Maximilian Ackermann, Hans-Joachim Anders, Rostyslav Bilyy, Gary L. Bowlin, Christoph Daniel, Rebecca De Lorenzo, Mikala Egeblad, Timo Henneck, Andres Hidalgo, Markus Hoffmann, et al.
Pages: 3125 - 3139 - Punching holes in cellular membranes : biology and evolution of gasdermins(2021)
Authors: Elke De Schutter, Ria Roelandt, Franck Riquet, Guy Van Camp, Peter Vandenabeele
Pages: 500 - 513 - Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor(2021)
Authors: Tom Delanghe, Jon Huyghe, Seungheon Lee, Dario Priem, Samya Van Coillie, Barbara Gilbert, Peter Vandenabeele, Alexei Degterev, Gregory D. Cuny, Yves Dondelinger, et al.
- MLKL in cancer : more than a necroptosis regulator(2021)
Authors: Sofie Martens, Jolien Bridelance, Ria Roelandt, Peter Vandenabeele, Nozomi Takahashi
Pages: 1757 - 1772 - Quantifying single-cell ERK dynamics in colorectal cancer organoids reveals EGFR as an amplifier of oncogenic MAPK pathway signalling(2021)
Authors: Bas Ponsioen, Jasmin B. Post, Julian R. Buissant des Amorie, Dimitrios Laskaris, Ravian L. van Ineveld, Simone Kersten, Andrea Bertotti, Francesco Sassi, François Sipieter, Benjamin Cappe, et al.
Pages: 377 - 390 - Characteristic ERK1/2 signaling dynamics distinguishes necroptosis from apoptosis(2021)
Authors: François Sipieter, Benjamin Cappe, Aymeric Leray, Elke De Schutter, Jolien Bridelance, Guy Van Camp, Laurent Heliot, Pierre Vincent, Peter Vandenabeele, Franck Riquet
Patents
1 - 6 of 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)